M4MM

Psilocybin Shows Promise in Treating Cocaine Addiction

BIRMINGHAM – For the first time, a peer-reviewed, randomized clinical trial showed that psilocybin significantly reduced cocaine use when combined with structured psychotherapy. The findings, published in JAMA Network Open by researchers at the University ...

RYTHM Reports Q1 2026 Financial Results

ROLLING MEADOWS – RHYTHM Inc. disclosed stronger results for the first quarter of 2026 as the company continued its shift toward branded hemp-derived THC products and licensing deals. Revenue from continuing operations came in at ...

Curaleaf Reports Q1 2026 Financial Results

STAMFORD – Curaleaf Holdings Inc. posted its strongest revenue growth in years during the first quarter of 2026, swinging to a net profit just as the federal regulatory environment under which the industry operates began ...

LeafLink Releases 2026 Wholesale Cannabis Pricing Guide

NEW YORK – LeafLink, a unified B2B marketplace and technology platform built specifically for the Cannabis industry, published its annual 2026 Wholesale Cannabis Pricing Guide, delivering one of the most comprehensive data snapshots the legal ...

Psilocybin Shows Promise in Treating Cocaine Addiction

BIRMINGHAM – For the first time, a peer-reviewed, randomized clinical trial showed that psilocybin significantly reduced cocaine use when combined with structured psychotherapy. The findings, published in JAMA Network Open by researchers at the University ...

Silo Pharma Initiates Safety Study for PTSD Drug SPC-15

LOS ANGELES- Silo Pharma Inc. a developmental-stage biopharmaceutical company, has commenced a 7-day safety and toxicology study for its lead candidate, SPC-15, an intranasal treatment targeting post-traumatic stress disorder (PTSD). The study is being conducted ...

  • Village Farms International

Village Farms International Reports Q1 2025

LOS ANGELES- Village Farms International Inc. has announced its financial results for the first quarter of 2025, highlighting a strategic pivot towards its cannabis operations and the privatization of certain fresh produce assets. For the ...

Cybin Secures Additional U.S. Patent for CYB003

LOS ANGELES- Cybin Inc. a biopharmaceutical company, announced the granting of U.S. patent 12,291,499 by the United States Patent and Trademark Office. This patent pertains to pharmaceutical compositions and oral dosage forms within the company's ...

Subscribe To Our Newsletter